Best i3 Podcasts (2025)

1
Redefining Hope in ALS: A Webinar Preview With Richard S. Bedlack, MD, PhD, MS 4:45

18d ago4:45

4:45

Join us for a special live webinar, Slowing Disease Progression and Optimizing Quality of Life for Patients With ALS, on Wednesday, June 11th at 1:00 pm Eastern. In this exclusive event, Dr. Richard S. Bedlack will share his expertise and latest insights on ALS care.In this preview interview, Dr. Bedlack discusses his unique approach to supporting …

1
From The Archive – Gilmour Space Technologies 26:10

22d ago26:10

26:10

In honour of Gilmour Space Technologies obtaining regulatory approval from the Australian Space Agency to launch its very first home-grown rocket into space, we bring you an interview with Adam Gilmour from January 2022. The Eris rocket is due to take off on Thursday morning.In Episode 66, we spoke with Adam Gilmour, who is the co-founder and Chief…

1
113: FCLT's Eduard van Gelderen – Long Term Investing, Concentrated Portfolios and Decarbonisation 44:38

29d ago44:38

44:38

Eduard van Gelderen is Head of Research for Focusing Capital on the Long Term (FCLT), an organisation that was established in the wake of the Global Financial Crisis, or Great Recession as it is known in the US, to move away from a so-called “quarterly capitalism”, which arguably contributed to the crisis, and towards a true long-term mind-set. Van…

1
Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes – Module 2 20:58

1M ago20:58

20:58

In this concluding module, Michael A. Davies, MD, PhD, University of Texas, MD Anderson Cancer Center, addresses the critical challenges of managing treatment-associated toxicities in the era of advanced melanoma therapies. Discover practical strategies for handling immune-related adverse events, implementing comprehensive supportive care, and opti…

1
Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes – Module 1 49:42

1M ago49:42

49:42

Join melanoma authority Michael A. Davies, MD, PhD, University of Texas, MD Anderson Cancer Center, as he navigates the latest breakthroughs in immunotherapy and targeted treatments transforming outcomes for patients with melanoma. Discover how predictive biomarkers, strategic combination therapies, and personalized treatment sequencing are revolut…

1
112: Fulcrum's Suhail Shaikh – Absolute Return Investing, Market Timing and The Role of Luck 46:33

1M ago46:33

46:33

Suhail Shaikh is Chief Investment Officer of Fulcrum Asset Management and is the portfolio manager of Fulcrum’s Discretionary Macro and Diversified Absolute Return strategies. In today’s incredibly volatile environment of tariff wars and deglobalisation, investors tend to be more sensitive about the level of their absolute returns, than their perfo…

1
Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies - Module 1 30:14

2M ago30:14

30:14

Join Dr. Mariana Castells, Director of the Mastocytosis Center at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School, in Module 1 of this podcast series as she explores the challenges of diagnosing systemic mastocytosis (SM), a rare and often under recognized mast cell disease. In this episode, Dr. Castells discusses t…

1
Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies - Module 2 27:41

2M ago27:41

27:41

Tune in to Module 2 of our podcast series as Dr. Mariana Castells, Director of the Mastocytosis Center at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School, explores strategies for developing personalized management plans for patients with systemic mastocytosis (SM). This episode covers the latest advancements in trea…

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 1 41:12

2M ago41:12

41:12

Schizophrenia is a debilitating mental illness that significantly impacts thought processes, perceptions, emotions, and social interactions. In Module 1 of this podcast, expert Dr. Christoph U. Correll explores the limitations of current dopamine-blocking therapies and discusses ongoing efforts to optimize treatment approaches. Stay informed on the…

1
Additional Advances in Relapsed/Refractory Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP 48:31

2M ago48:31

48:31

The fight against relapsed/refractory multiple myeloma is evolving rapidly, with groundbreaking research and clinical trials paving the way for innovative treatments. But as new therapies emerge, addressing healthcare disparities and improving access to these life-changing advancements has never been more critical.In this episode, Dr. Rahul Banerje…

1
Additional Advances in Plaque Psoriasis Clinical Trials and Research With Steven Feldman, MD, PhD 9:58

2M ago9:58

9:58

Plaque psoriasis is more than just a skin condition—it’s a chronic, immune-mediated disorder that can deeply affect a person’s quality of life. That’s why it’s essential for healthcare professionals to develop effective patient education strategies that address safety concerns, improve communication, and encourage therapy adherence.In this episode,…

1
111: ART's Michael Weaver – The Role of Real Assets in a Pension Portfolio 34:36

2M ago34:36

34:36

In episode 111 of the [i3] Podcast, we speak with Michael Weaver, who is the Head of Global Real Assets with the Australian Retirement Trust. We discussed the role of real assets in the context of a multi-asset, pension portfolio, the ever-lurking threat of inflation, the return of office property and more. Please enjoy the show!Overview of Podcast…

1
108: Victory Park Capital's Brendan Carroll – Private Credit, Asset-backed Lending, ChatGPT 35:56

2M ago35:56

35:56

Private credit has evolved significantly since the global financial crisis, and Brendan Carroll, Senior Partner at Victory Park Capital, has been at the forefront of that transformation. In this episode, we explore how private credit investments are adapting to meet the needs of insurers, the growing role of asset-backed lending, and why insurance …

1
Additional Advances in ALS Clinical Trials and Research With Sabrina Paganoni, MD, PhD + Module 2 22:30

2M ago22:30

22:30

In this episode, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts General Hospital, discusses the latest advancements in early diagnosis and treatment of amyotrophic lateral sclerosis (ALS), a progressive neurological disorder that leads to motor neuron degeneration and muscle atrophy. Following the…

1
Additional Advances in ALS Clinical Trials and Research with Sabrina Paganoni, MD, PhD + Module 1 Activity 29:41

2M ago29:41

29:41

In this episode, we explore amyotrophic lateral sclerosis (ALS) with Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts General Hospital, who shares insights on early detection and emerging treatments for this progressive neurological disorder. Following the interview, listeners can participate in an …

1
Additional Advances in Stem Cell Mobilization Research and Clinical Trials in Multiple Myeloma With Hamza Hashmi, MD 8:23

3M ago8:23

8:23

March marks Multiple Myeloma Awareness Month, a crucial time to highlight advances in the treatment of this complex blood cancer. Multiple myeloma is the leading indication of autologous hematopoietic stem cell transplantation (ASCT) in hematologic malignancies, with high-dose therapy followed by ASCT representing a potentially curative treatment m…

1
110: Allspring Global Investment's Jamie Newton – Is Now The Time to Add Duration? 30:29

3M ago30:29

30:29

In episode 110 of the [i3] Podcast, we speak with Jamie Newton, Head of Global Fixed Income Research and Deputy Head of Sustainability at Allspring Global Investments. We discuss why now is a good time to add duration to fixed income portfolios, concerns over the lack of experience with high default rates in private credit and opportunities in data…

1
Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC 10:31

3M ago10:31

10:31

As we recognize Kidney Cancer Awareness Month this March, advancements in renal cell carcinoma (RCC) treatment continue to evolve. Recently, Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC, a Nurse Practitioner and expert in genitourinary oncology, chaired the i3 Health’s NCPD activity titled Toxicity Management and Symptom Control in Advanced RCC: Playb…

1
Additional Advances in MCED Technologies: MCED Testing and Shared Decision Making + Module 3 Activity 28:55

3M ago28:55

28:55

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with M…

1
Additional Advances in MCED Technologies: Cancer Survivorship and Emerging Trials + Module 2 Activity 24:24

3M ago24:24

24:24

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with M…

1
Additional Advances in MCED Technologies: The Impact of MCED Testing + Module 1 Activity 25:48

3M ago25:48

25:48

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with M…

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 4 18:20

4M ago18:20

18:20

Schizophrenia is a highly complex and multifactorial mental illness, with symptoms, presentations, and outcomes varying widely among individuals. Genetic, environmental, and personal factors all play a role in disease progression, making individualized treatment essential for optimal outcomes.In Module 4 of this podcast, expert Dr. Christoph U. Cor…

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 3 19:10

4M ago19:10

19:10

Cognitive impairment is a core feature of schizophrenia, significantly contributing to functional disability and long-term challenges. Patients often experience poor attention, disorientation, stereotyped thinking, and difficulty with abstract thought, all of which hinder daily functioning and independence.In Module 3 of this podcast, expert Dr. Ch…

1
109: Is DeepSeek What It Promised To Be? – Will Liang Explains New AI Model 28:09

4M ago28:09

28:09

In episode 109, we are back with Will Liang, Executive Director at MA Financial, to discuss the introduction of DeepSeek and the impact on the future development of artificial intelligence and the global economy. Are tech firms going to scale back their investments due to this low cost model, or is it all a bit of a hype? Enjoy the Show!Overview of…

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 2 21:04

4M ago21:04

21:04

Schizophrenia affects over 24 million people worldwide, yet treatment adherence remains a significant challenge due to side effects and complex dosing schedules of oral antipsychotics. Long-acting injectables (LAIs) offer a promising alternative, providing less frequent dosing, improved adherence, and more stable blood concentrations, which may lea…

1
Additional Advances in Hemophilia Research and Clinical Trials With Guy Young, MD 54:33

4M ago54:33

54:33

Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology-Oncology, and Professor of Pediatrics at Keck School of Medicine at the University of Southern California (USC), is currently serving as co-chair of i3 Health’s CME/NCPD activity, Practice-Changing Advances in the Management of Hemophilia. With new d…

1
Implementing AI Into Healthcare Education: The Ethical and Legal Landscape 22:20

4M ago22:20

22:20

Implementing AI Into Healthcare Education: The Ethical and Legal Landscape by i3 HealthBy i3 Health

1
107: Scott Donald on Governance and Member Meetings 39:07

6M ago39:07

39:07

In episode 107 of the [i3] Institutional Investment Podcast, we speak with Scott Donald, Associate Professor at the School of Private and Commercial Law of the University of New South Wales, about his research into governance and the now mandatory annual member meetings of superannuation funds. How do funds field questions from members? How can we …

1
Best Practices and Emerging Evidence in the Treatment of Atopic Dermatitis in Children and Adolescents 35:40

6M ago35:40

35:40

Tune in to the latest podcast episode, Best Practices and Emerging Evidence in the Treatment of Atopic Dermatitis in Children and Adolescents, where experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold discuss cutting-edge advancements in pediatric AD care. Learn about new therapies, including nonsteroidal topicals, JAK inhibitors, monoclonal antib…

1
What’s New With HER2: Charting New Paths in NSCLC Care Module 1 Podcast: HER2 in NSCLC: Actionable Insights and Testing Recommendations 15:24

6M ago15:24

15:24

Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions.In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cance…

1
What’s New With HER2: Charting New Paths in NSCLC Care Module 2 Podcast 18:34

6M ago18:34

18:34

Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies.In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-F…

1
Diagnosis and Management of Dedifferentiated Liposarcoma: A Multidisciplinary Task Force Podcast 28:57

7M ago28:57

28:57

Gain valuable insights into the complexities of diagnosing and managing dedifferentiated liposarcoma (DDLPS) and earn free CME credit with our latest podcast. This episode features expert guidance from Dr. Richard F. Riedel of Duke University and Dr. Candace L. Haddox of Dana-Farber Cancer Institute. Delve into the latest on identifying MDM2 and CD…

1
106: Tuckwell Family Office's Craig Dandurand 59:24

7M ago59:24

59:24

In episode 106 of the [i3] Institutional Investment Podcast, I speak with Craig Dandurand, Chief Investment Officer of the Tuckwell Family Office. Craig has an impressive career in the investment industry that spans time with US pension fund CalPERS and Australia's the Future Fund. We talked about his background in credit investing, setting up a he…

1
National Alzheimer Disease Awareness Month: Advances in Diagnosis and Research With Nathaniel Chin, MD 14:25

7M ago14:25

14:25

Click the links below for the full activity! Online Accredited CME/NCPD Activity: https://i3health.com/course-information/Alzheimer-disease Live In-Person or Virtual Meeting: https://i3health.com/live/Exploring%20Advances%20in%20the%20Early%20Diagnosis%20and%20Treatment%20of%20Alzheimer%20DiseaseNovember is National Alzheimer Disease Awareness Mont…

1
105: T. Rowe Price's Jessica Sclafani 29:20

7M ago29:20

29:20

In episode 105 of the [i3] Institutional Investment Podcast, we speak with Jessica Sclafani, a Global Retirement Strategist with US fund manager T. Rowe Price, which manages $1.6 trillion in total assets on behalf of clients. Retirement is a more complex phase than wealth accumulation and it needs a more sophisticated approach to deliver good outco…

1
Exclusive Sneak Peek: Unlocking What's Next in Genetic Counseling and Cancer Care! 9:30

8M ago9:30

9:30

i3 Health is pleased to invite you to Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, a free, live webinar held on November 7 at 10:00 am Eastern and November 19 at 11:30 am Eastern. This interview features an exclusive preview from the two webinar co-chairs, Dr. Filipa Lynce, Director of the Inflammatory Breast …

1
104: State Super's John Livanas 45:19

8M ago45:19

45:19

John Livanas is the Chief Executive Officer of State Super, the $37 billion superannuation fund for public service and public sector workers in NSW. In this episode, we talk about the use of defensive overlays, dealing with the COVID drawdown and machine learning in investments. Enjoy the show!Overview of podcast with John Livanas, Chief Executive …

1
Additional Advances in Head and Neck Squamous Cell Carcinoma With Deborah Wong, MD, PhD 9:12

8M ago9:12

9:12

Dr. Deborah Wong, Director of the Medical Oncology Program and Clinical Trials Program for Head and Neck Squamous Cell Cancers (HNSCC) and an Associate Clinical Professor of Medicine at the University of California Los Angeles (UCLA) is currently serving as co-chair of i3 Health’s accredited CME/NCPD activity, Recurrent and Metastatic HNSCC, Harnes…

1
Navigating Patients Through the CKD Journey by Enhancing Value-Based Care - CPE & Interview 1:55:41

8M ago1:55:41

1:55:41

Jeff Sperry, PharmD, BCPS, a Clinical Pharmacist at UCHealth Memorial Hospital, sat down with the Pharmacy Podcast Network to discuss additional advances in chronic kidney disease since recording the i3Health CPE-accredited activity, Slowing Progression of Chronic Kidney Disease Through Value-Based Care. Following the interview, continue listening …

1
Additional Advances in Alzheimer Disease Research and Clinical Trials With Nathaniel Chin, MD 14:18

9M ago14:18

14:18

Dr. Nathaniel Chin, Associate Professor of Medicine in the Division of Geriatrics and Gerontology at the University of Wisconsin-Madison, is currently serving as chair of i3 Health’s accredited CME/NCPD activity, Exploring Advances in the Early Diagnosis and Treatment of Alzheimer Disease. With new developments in the field occurring over recent mo…

1
Multicancer Early Detection Technologies: Module 3 - Implementing MCED Testing in Clinical Practice 23:43

9M ago23:43

23:43

Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.In Module 3 of our CME podcast, Dr. Charles Vega, Clinical Professor at the University of California, Irvine, will review the latest clinical trial data on MCED tests for gynecologi…

1
Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory MM 33:18

9M ago33:18

33:18

Listen now to this CME-accredited podcast, part of the Multiple Myeloma Task Force series, where we will explore strategies for mitigating disease burden and addressing health care disparities in patients with relapsed/refractory multiple myeloma. This session brings together expert insights from Task Force Co-Chairs, Dr. Sikander Ailawadhi, Profes…

1
103: Janus Henderson's Matt Culley 44:19

9M ago44:19

44:19

Matthew Culley is a Portfolio Manager on the Emerging Market Equity Team at Janus Henderson Investors. In this podcast, we talk about the best performing markets, tensions around China, the impact of the US elections and fighter jets. Enjoy the Show!Overview of [i3] Podcast with Matt Culley, Janus Henderson Investors02:00 I initially wanted to beco…

1
Multicancer Early Detection Technologies: Module 2 - Clinical Evidence for MCED Testing 20:13

10M ago20:13

20:13

Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.Join Dr. Charles Vega in Module 2 of our CME podcast as he delves into the cutting-edge world of multicancer early detection (MCED) tests. With nearly 2 million new cancer cases exp…

1
Multicancer Early Detection Technologies: Module 1 - Science Behind Cancer Screening 20:16

10M ago20:16

20:16

Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. Listen now to Module 1 and join Dr. Charles Vega, a distinguished Clinical Professor from UC Irvine, as he explores the cutting-edge realm of multicancer early detection (MCED). Dr…

1
102: Qantas Super's Andrew Spence 44:49

10M ago44:49

44:49

In episode 102 of the [i3] Podcast, we speak with Andrew Spence, Chief Investment Officer of the $9 billion corporate super fund Qantas Super. Qantas Super recently announced to merge with ART and we took the opportunity to look back at the investment strategy that Spence put in place as the fund's first CIO, the innovations along the way and lesso…

1
Additional Advances in Rett Syndrome Research and Clinical Trials With Timothy John Feyma, MD 5:00

11M ago5:00

5:00

Dr. Timothy John Feyma, Pediatric Neurologist at Gillette Children’s Hospital, is currently serving as chair of i3 Health’s CME/NCPD activity, Exploring Novel Treatments for Rett Syndrome. With new developments in the field occurring over recent months, Dr. Feyma sat down with us again to share new updates in treatment and management of Rett syndro…

1
101: ECP's Damon Callaghan and Sam Byrnes 47:22

11M ago47:22

47:22

In episode 101 of the [i3] Podcast, we speak with Damon Callaghan and Sam Byrnes of asset management firm ECP. ECP was established by Dr. Manny Pohl of Hyperion Asset Management fame and in this episode we talk about the opportunities and challenges of artificial intelligence when investing in Australian equities. Enjoy the show!01:00 How we got st…

1
Practice-Changing Advances in the Management of Hemophilia 42:37

12M ago42:37

42:37

In this podcast, hear expert perspectives on practice-changing advances in the treatment and personalized management of patients with hemophilia from Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology/Oncology, and Professor of Pediatrics at Keck School of Medicine of USC; and Dr. Jennifer Davila, Co…

1
Early-Stage Non–Small Cell Lung Cancer: Answers to Frequently Asked Questions 5:58

12M ago5:58

5:58

In this video, Dr. Jamie E. Chaft, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Leveraging the Growing Arsenal of Therapies for Early-Stage Non–Small Cell Lung Cancer (NSCLC), chaired by Dr. Helena Yu. Dr. Chaft shares insights …

Podcasts Worth a Listen

I3 Podcasts

Podcasts Worth a Listen